Both in Pharmaceuticals
Greenwich LifeSciences vs Lifecore Biomedical
Over the past year GLSI returned +95.3% and LFCR returned −10.1%; their daily moves had a correlation of 0.08.
GLSI +95.3% LFCR −10.1%Growth of $1, one year, split-adjusted
| Metric | GLSI | LFCR |
|---|---|---|
| Price | $16.46 | $6.39 |
| Market cap | $241.6M | $242.2M |
| Today | −5.46% | −0.16% |
| 1 month | −3.1% | −2.3% |
| 6 months | −25.1% | +24.6% |
| Year to date | −21.7% | −21.9% |
| 1 year | +79.1% | −10.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 35.3% |
| Net margin | — | −20.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.9M | -$136.9M |
| Dividend yield | — | — |
| Volatility (60d) | 92.9% | 98.2% |
| Short % of float | 24.5% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).